Health Care & Life Sciences » Biotechnology | Onconova Therapeutics Inc.

Onconova Therapeutics Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
62,556.00
63,795.00
24,023.00
19,667.00
24,092.00
20,410
Depreciation, Depletion & Amortization
446.00
434.00
150.00
96.00
88.00
55
Other Funds
496.00
500.00
-
-
-
1,274
Funds from Operations
54,178.00
58,319.00
20,065.00
19,630.00
23,922.00
21,629
Changes in Working Capital
7,206.00
671.00
11,248.00
3,817.00
102.00
1,067
Net Operating Cash Flow
61,384.00
57,648.00
31,313.00
15,813.00
23,820.00
22,696
Capital Expenditures
609.00
228.00
-
-
-
Purchase/Sale of Investments
39,990.00
40,000.00
-
-
-
Net Investing Cash Flow
40,599.00
39,772.00
-
-
-
Net Financing Cash Flow
80,464.00
1,463.00
7,464.00
17,423.00
6,360.00
Net Change in Cash
21,518.00
16,427.00
23,858.00
1,601.00
17,426.00
Free Cash Flow
61,993.00
57,876.00
31,313.00
15,813.00
23,820.00
Change in Capital Stock
79,968.00
963.00
7,464.00
17,423.00
6,360.00
Exchange Rate Effect
1.00
14.00
9.00
9.00
34.00

About Onconova Therapeutics

View Profile
Address
375 Pheasant Run
Newtown Pennsylvania 18940
United States
Employees -
Website http://www.onconova.com
Updated 07/08/2019
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.